DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model. (Q37866631)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

title

DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

0 references

Chlamydia pneumoniae

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

Mirja Puolakkainen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Tuula Penttilä

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

Anne Tammiruusu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

Matti Sarvas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

P Helena Mäkelä

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

Jenni M Vuola

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

issue

25-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

3386-3394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Chlamydia pneumoniae (TWAR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Experimental infection of Chlamydia pneumoniae in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Depletion of CD8 cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Protective DNA immunization against Chlamydia pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Alphavirus expression vectors and their use as recombinant vaccines: a minireview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Alphavirus vectors for gene therapy applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

The Semliki Forest virus vector induces p53-independent apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Enhanced immunogenicity for CD8 T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8 T cell immunogenicity and protective efficacy in the influenza and malaria models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

SYFPEITHI: database for MHC ligands and peptide motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

CpG motifs in bacterial DNA and their immune effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

The prime-boost strategy: exciting prospects for improved vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Overexpression and surface localization of the Chlamydia trachomatis major outer membrane protein in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Expression and translocation of the chlamydial major outer membrane protein in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

7 January 2021

Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

7 January 2021

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

7 January 2021

In vitro neutralization of Chlamydia trachomatis by monovalent Fab antibody specific to the major outer membrane protein

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

7 January 2021

Serological response to Chlamydia pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2004.02.032

7 January 2021

10.1016/J.VACCINE.2004.02.032

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15308363 AND SRC:MED&resulttype=core&format=json

31 December 2019

1 reference